imidazo(1,2-a)pyridine has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soural, M; Vanda, D; Zajdel, P | 1 |
| Uto, Y | 1 |
| Blache, Y; Chavignon, O; Chezal, JM; Delmas, G; Grassy, G; Gueiffier, A; Lartigue, C; Moreau, E; Teulade, JC | 1 |
1 review(s) available for imidazo(1,2-a)pyridine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.
Topics: Animals; Clinical Trials as Topic; Drug Design; Humans; Imidazoles; Ligands; Mental Disorders; Molecular Targeted Therapy; Neurodegenerative Diseases; Pyridines | 2019 |
2 other study(ies) available for imidazo(1,2-a)pyridine and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).
Topics: Animals; Cholesterol 24-Hydroxylase; Cytochrome P-450 Enzyme Inhibitors; Humans; Neurodegenerative Diseases; Patents as Topic; Pyridines; Steroid Hydroxylases | 2015 |
Heterocyclization of functionalized vinylic derivatives of imidazo.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Heterocyclic Compounds; Humans; Models, Molecular; Neurodegenerative Diseases; Pyridines | 2001 |